Gene · 2921
Papers3,842
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,861 to 1,880 of 3,842
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| LINC00483 Has a Potential Tumor-Suppressor Role in Colorectal Cancer Through Multiple Molecular Axes. | Front Oncol | 2020 | 33552987 | PubTator, text mining | PubMed |
| Transcriptome Based System Biology Exploration Reveals Homogeneous Tumorigenicity of Alimentary Tract Malignancy. | Front Oncol | 2020 | 33552958 | PubTator, text mining | PubMed |
| CSF3 Is a Potential Drug Target for the Treatment of COVID-19. | Front Physiol | 2020 | 33551833 | PubTator, text mining | PubMed |
Gene Expression Profiling Reveals the Shared and Distinct Transcriptional Signatures in Human Lung Epithelial Cells Infected With SARS-CoV-2, MERS-CoV, or SARS-CoV: Potential Implications in Cardiovascular Complications of COVID-19. | Front Cardiovasc Med | 2020 | 33521069 | PubTator, text mining | PubMed |
| A THP-1 Cell Line-Based Exploration of Immune Responses Toward Heat-Treated BLG. | Front Nutr | 2020 | 33521038 | PubTator, text mining | PubMed |
| HEYL Regulates Neoangiogenesis Through Overexpression in Both Breast Tumor Epithelium and Endothelium. | Front Oncol | 2020 | 33520697 | PubTator, text mining | PubMed |
| Analysis of the Prognosis and Therapeutic Value of the CXC Chemokine Family in Head and Neck Squamous Cell Carcinoma. | Front Oncol | 2020 | 33489879 | PubTator, text mining | PubMed |
| Genetic predisposition and prediction protocol for epithelial neoplasms in disease-free individuals: A systematic review. | J Oral Maxillofac Pathol | 2020 | 33456239 | PubTator, text mining | PubMed |
| To promote or inhibit glioma progression, that is the question for IL-33. | Cell Stress | 2020 | 33447733 | PubTator, text mining | PubMed |
| Infiltration of Immunoinflammatory Cells and Related Chemokine/Interleukin Expression in Different Gastric Immune Microenvironments. | J Immunol Res | 2020 | 33426088 | PubTator, text mining | PubMed |
| Mechanisms of Immunosuppression in Colorectal Cancer. | Cancers (Basel) | 2020 | 33419310 | PubTator, text mining | PubMed |
| Immune Characterization of Ovarian Cancer Reveals New Cell Subtypes With Different Prognoses, Immune Risks, and Molecular Mechanisms. | Front Cell Dev Biol | 2020 | 33409283 | PubTator, text mining | PubMed |
| Role of Cardiac Macrophages on Cardiac Inflammation, Fibrosis and Tissue Repair. | Cells | 2020 | 33396359 | PubTator, text mining | PubMed |
| Role of gut microbiome in regulating the effectiveness of metformin in reducing colorectal cancer in type 2 diabetes. | World J Clin Cases | 2020 | 33392303 | PubTator, text mining | PubMed |
| Myeloid-Derived Suppressor Cells: A New and Pivotal Player in Colorectal Cancer Progression. | Front Oncol | 2020 | 33384962 | PubTator, text mining | PubMed |
| The Many Faces of CD4+ T Cells: Immunological and Structural Characteristics. | Int J Mol Sci | 2020 | 33374787 | PubTator, text mining | PubMed |
| Common and Differential Dynamics of the Function of Peripheral Blood Mononuclear Cells between Holstein and Jersey Cows in Heat-Stress Environment. | Animals (Basel) | 2020 | 33374309 | PubTator, text mining | PubMed |
| Trained immunity as a novel approach against COVID-19 with a focus on Bacillus Calmette-Guérin vaccine: mechanisms, challenges and perspectives. | Clin Transl Immunology | 2020 | 33363733 | PubTator, text mining | PubMed |
| Multi-Omics Analysis of Diabetic Nephropathy Reveals Potential New Mechanisms and Drug Targets. | Front Genet | 2020 | 33362869 | PubTator, text mining | PubMed |
| NF-κB Pathway as a Potential Target for Treatment of Critical Stage COVID-19 Patients. | Front Immunol | 2020 | 33362782 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2921/papers?page=94